XML 37 R26.htm IDEA: XBRL DOCUMENT v3.4.0.3
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2016
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis

 The following fair value hierarchy table presents information about the Company’s assets and liabilities measured at fair value on a recurring basis at March 31, 2016 and December 31, 2015:

 

March 31,2016

(Thousands of dollars)

  Quoted Prices in
Active Markets
For Identical
Assets (Level 1)
     Significant
Other
Observable
Inputs (Level 2)
     Significant
Unobservable
Inputs (Level 3)
     Balance at
March 31,
2016
 

Liabilities

          

Interest rate derivative contracts

  $ —        $ —        $ —         $ —     
 

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

  $ —        $ —        $ —         $ —     
 

 

 

    

 

 

    

 

 

    

 

 

 

December 31, 2015

(Thousands of dollars)

  Quoted Prices in
Active Markets
For Identical
Assets (Level 1)
     Significant
Other
Observable
Inputs (Level 2)
     Significant
Unobservable
Inputs (Level 3)
     Balance at
December 31,
2015
 

Liabilities

          

Interest rate derivative contracts

  $ —        $ —        $ (7    $ (7
 

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

  $ —        $ —        $ (7    $ (7
 

 

 

    

 

 

    

 

 

    

 

 

 

Schedule of Changes in Fair Value of Financial Assets and Liabilities Classified as Level 3

The following table sets forth a reconciliation of changes in the fair value of financial assets and liabilities classified as Level 3 in the fair value hierarchy for the three months ended March 31, 2016.

 

(Thousands of dollars)       

Net Liabilities – December 31, 2015

   $ (7

Total realized and unrealized (gains) losses:

  

Included in earnings (a)

     7   

Included in other comprehensive loss

     —     

Purchases, sales, issuances and settlements

     —     
  

 

 

 

Net assets(liabilities) – March 31, 2016

   $ —     
  

 

 

 

 

(a) Derivative instruments are reported in revenues as realized gain/loss and on a separately reported line item captioned unrealized gain/loss on derivative instruments, and interest rate swap instruments are reported as an increase or reduction to interest expense.
Effect of Derivative Instruments on Consolidated Balance Sheets

The following table sets forth the effect of derivative instruments on the consolidated balance sheets at March 31, 2016 and December 31, 2015:

 

            Fair Value at December 31,  

(Thousands of dollars)

   Balance Sheet Location      March 31,
2016
     December 31,
2015
 

Liability Derivatives:

  

Derivatives designated as cash-flow hedging instruments:

        

Interest rate swap contracts

     Derivative liability short-term       $ —         $ (7
     

 

 

    

 

 

 

Total

      $ —         $ (7
     

 

 

    

 

 

 

Total derivative instruments

      $ —         $ (7
     

 

 

    

 

 

 

 

Effect of Derivative Instruments on Consolidated Statements of Operations


The following table sets forth the effect of derivative instruments on the consolidated statements of operations for the three month period ended March 31, 2016 and 2015:

 

    

Location of gain/loss recognized
in income

   Amount of gain/loss
recognized in income
 

(Thousands of dollars)

      2016      2015  

Derivative designated as cash-flow hedge instruments:

        

Interest rate swap contracts

  

Interest expense

   $ (7    $ (74

Derivatives not designated as cash-flow hedge instruments:

        

Natural gas commodity contracts

  

Unrealized (loss) gain on derivative instruments, net

     —           (193

Crude oil commodity contracts

  

Unrealized (loss) gain on derivative instruments, net

     —           (2,273

Natural gas commodity contracts

  

Realized gain (loss) on derivative instruments, net

     —           592   

Crude oil commodity contracts

  

Realized gain on derivative instruments, net

     —           4,551   
     

 

 

    

 

 

 
      $ (7    $ 2,603